⚕ For healthcare professionals & patients — informational use only, not a substitute for medical advice. 15,548 products indexed

BMP-E

BEMPEDOIC ACID AND EZETIMIBE · by HILTON

LIPID MODIFYING AGENTS Adenosine triphosphate-citratelyase (ACL) inhibitor/ Cholesterol absorption inhibitor HILTON

Composition

Tab180/10 mg: Bempedoic Acid 180 mg and Ezetimibe 10 mg

Indications & Dosage

Primary hypercholesterolaemia, hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH) or mixed dyslipidaemia (in combination with a statin, or alone if a statin is contra-indicated or not tolerated): Adult: 180/10 mg daily To reduce the risk of myocardial infarction and coronary revascularization (when statin therapy is inappropriate) with established cardiovascular disease (CVD), or a high risk for a CVD event: Adult: 180/10 mg once daily.

Contraindications

Serious hypersensitivity reactions, such as angioedema, rash and urticaria.

Precautions

Severe renal impairment, severe hepatic impairment (Child-Pugh C). Analyze lipid levels within 8 to 12 weeks.

Interactions

Simvastatin, Pravastatin, Cyclosporine, Fibrates

Pregnancy

Avoid, unless the benefits outweigh the potential risks

Lactation

Avoid

Side Effects

Abdominal pain or discomfort, angioedema, hyperuricemia, tendinitis or tendon rupture, anaemia, gout, pain in extremity, diarrhoea, muscle spasms, nausea, wheezing, Elevated liver enzyme.